A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, lung adenocarcinoma, lung disorder, lung neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, non-small cell squamous lung carcinoma, respiratory system disorder, respiratory tract neoplasm, urinary system disorder	Active, not recruiting	Phase 1	2026-09-30		NCT05873686

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nuvectis Pharma, Inc.	3

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cleveland Clinic	Cleveland	United States	558
Mayo Clinic	Phoenix	United States	50
Mayo Clinic	Jacksonville	United States	122
Mayo Clinic Rochester	Rochester	United States	133
Memorial Sloan Kettering Cancer Center	New York	United States	60
NEXT Oncology Dallas	Irving	United States	9
NEXT Oncology Houston	Houston	United States	5
NEXT Oncology Virginia	Fairfax	United States	40
Oregon Health and Science University	Portland	United States	382
Sarah Cannon Research Institute at HealthOne	Denver	United States	34
The Royal Marsden NHS Foundation and Trust	London	United Kingdom	1
The University of Texas MD Anderson Cancer Center	Houston	United States	207
UC San Diego Moores Cancer Center	La Jolla	United States	199
University of Chicago	Chicago	United States	312
Western General Hospital - NHS Lothian	Edinburgh	United Kingdom	1